Global DNA Vaccination Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 280279
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The DNA Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global DNA Vaccination market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the DNA Vaccination global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Human DNA Vaccines segment is altered to a % CAGR between 2022 and 2028.

Global key companies of DNA Vaccination include Inovio Pharmaceuticals, Merck, Astellas Pharma, Pfizer, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

DNA Vaccination market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Human DNA Vaccines

Animal DNA Vaccines

Market segment by Application, can be divided into

Hospitals

Research and Academic Laboratories

Others

Market segment by players, this report covers

Inovio Pharmaceuticals

Merck

Astellas Pharma

Pfizer

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe DNA Vaccination product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of DNA Vaccination, with revenue, gross margin and global market share of DNA Vaccination from 2019 to 2022.

Chapter 3, the DNA Vaccination competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and DNA Vaccination market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe DNA Vaccination research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of DNA Vaccination

1.2 Classification of DNA Vaccination by Type

1.2.1 Overview: Global DNA Vaccination Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global DNA Vaccination Revenue Market Share by Type in 2021

1.2.3 Human DNA Vaccines

1.2.4 Animal DNA Vaccines

1.3 Global DNA Vaccination Market by Application

1.3.1 Overview: Global DNA Vaccination Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Research and Academic Laboratories

1.3.4 Others

1.4 Global DNA Vaccination Market Size & Forecast

1.5 Global DNA Vaccination Market Size and Forecast by Region

1.5.1 Global DNA Vaccination Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global DNA Vaccination Market Size by Region, (2017-2022)

1.5.3 North America DNA Vaccination Market Size and Prospect (2017-2028)

1.5.4 Europe DNA Vaccination Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific DNA Vaccination Market Size and Prospect (2017-2028)

1.5.6 South America DNA Vaccination Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa DNA Vaccination Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 DNA Vaccination Market Drivers

1.6.2 DNA Vaccination Market Restraints

1.6.3 DNA Vaccination Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Inovio Pharmaceuticals

2.1.1 Inovio Pharmaceuticals Details

2.1.2 Inovio Pharmaceuticals Major Business

2.1.3 Inovio Pharmaceuticals DNA Vaccination Product and Solutions

2.1.4 Inovio Pharmaceuticals DNA Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Inovio Pharmaceuticals Recent Developments and Future Plans

2.2 Merck

2.2.1 Merck Details

2.2.2 Merck Major Business

2.2.3 Merck DNA Vaccination Product and Solutions

2.2.4 Merck DNA Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Merck Recent Developments and Future Plans

2.3 Astellas Pharma

2.3.1 Astellas Pharma Details

2.3.2 Astellas Pharma Major Business

2.3.3 Astellas Pharma DNA Vaccination Product and Solutions

2.3.4 Astellas Pharma DNA Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Astellas Pharma Recent Developments and Future Plans

2.4 Pfizer

2.4.1 Pfizer Details

2.4.2 Pfizer Major Business

2.4.3 Pfizer DNA Vaccination Product and Solutions

2.4.4 Pfizer DNA Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Pfizer Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global DNA Vaccination Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 DNA Vaccination Players Market Share in 2021

3.2.2 Top 10 DNA Vaccination Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 DNA Vaccination Players Head Office, Products and Services Provided

3.4 DNA Vaccination Mergers & Acquisitions

3.5 DNA Vaccination New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global DNA Vaccination Revenue and Market Share by Type (2017-2022)

4.2 Global DNA Vaccination Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global DNA Vaccination Revenue Market Share by Application (2017-2022)

5.2 Global DNA Vaccination Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America DNA Vaccination Revenue by Type (2017-2028)

6.2 North America DNA Vaccination Revenue by Application (2017-2028)

6.3 North America DNA Vaccination Market Size by Country

6.3.1 North America DNA Vaccination Revenue by Country (2017-2028)

6.3.2 United States DNA Vaccination Market Size and Forecast (2017-2028)

6.3.3 Canada DNA Vaccination Market Size and Forecast (2017-2028)

6.3.4 Mexico DNA Vaccination Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe DNA Vaccination Revenue by Type (2017-2028)

7.2 Europe DNA Vaccination Revenue by Application (2017-2028)

7.3 Europe DNA Vaccination Market Size by Country

7.3.1 Europe DNA Vaccination Revenue by Country (2017-2028)

7.3.2 Germany DNA Vaccination Market Size and Forecast (2017-2028)

7.3.3 France DNA Vaccination Market Size and Forecast (2017-2028)

7.3.4 United Kingdom DNA Vaccination Market Size and Forecast (2017-2028)

7.3.5 Russia DNA Vaccination Market Size and Forecast (2017-2028)

7.3.6 Italy DNA Vaccination Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific DNA Vaccination Revenue by Type (2017-2028)

8.2 Asia-Pacific DNA Vaccination Revenue by Application (2017-2028)

8.3 Asia-Pacific DNA Vaccination Market Size by Region

8.3.1 Asia-Pacific DNA Vaccination Revenue by Region (2017-2028)

8.3.2 China DNA Vaccination Market Size and Forecast (2017-2028)

8.3.3 Japan DNA Vaccination Market Size and Forecast (2017-2028)

8.3.4 South Korea DNA Vaccination Market Size and Forecast (2017-2028)

8.3.5 India DNA Vaccination Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia DNA Vaccination Market Size and Forecast (2017-2028)

8.3.7 Australia DNA Vaccination Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America DNA Vaccination Revenue by Type (2017-2028)

9.2 South America DNA Vaccination Revenue by Application (2017-2028)

9.3 South America DNA Vaccination Market Size by Country

9.3.1 South America DNA Vaccination Revenue by Country (2017-2028)

9.3.2 Brazil DNA Vaccination Market Size and Forecast (2017-2028)

9.3.3 Argentina DNA Vaccination Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa DNA Vaccination Revenue by Type (2017-2028)

10.2 Middle East & Africa DNA Vaccination Revenue by Application (2017-2028)

10.3 Middle East & Africa DNA Vaccination Market Size by Country

10.3.1 Middle East & Africa DNA Vaccination Revenue by Country (2017-2028)

10.3.2 Turkey DNA Vaccination Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia DNA Vaccination Market Size and Forecast (2017-2028)

10.3.4 UAE DNA Vaccination Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global DNA Vaccination Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global DNA Vaccination Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market DNA Vaccination Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global DNA Vaccination Revenue (USD Million) by Region (2017-2022)

Table 5. Global DNA Vaccination Revenue Market Share by Region (2023-2028)

Table 6. Inovio Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 7. Inovio Pharmaceuticals Major Business

Table 8. Inovio Pharmaceuticals DNA Vaccination Product and Solutions

Table 9. Inovio Pharmaceuticals DNA Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Merck Corporate Information, Head Office, and Major Competitors

Table 11. Merck Major Business

Table 12. Merck DNA Vaccination Product and Solutions

Table 13. Merck DNA Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Astellas Pharma Corporate Information, Head Office, and Major Competitors

Table 15. Astellas Pharma Major Business

Table 16. Astellas Pharma DNA Vaccination Product and Solutions

Table 17. Astellas Pharma DNA Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Pfizer Corporate Information, Head Office, and Major Competitors

Table 19. Pfizer Major Business

Table 20. Pfizer DNA Vaccination Product and Solutions

Table 21. Pfizer DNA Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Global DNA Vaccination Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 23. Global DNA Vaccination Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 24. Breakdown of DNA Vaccination by Company Type (Tier 1, Tier 2 and Tier 3)

Table 25. DNA Vaccination Players Head Office, Products and Services Provided

Table 26. DNA Vaccination Mergers & Acquisitions in the Past Five Years

Table 27. DNA Vaccination New Entrants and Expansion Plans

Table 28. Global DNA Vaccination Revenue (USD Million) by Type (2017-2022)

Table 29. Global DNA Vaccination Revenue Share by Type (2017-2022)

Table 30. Global DNA Vaccination Revenue Forecast by Type (2023-2028)

Table 31. Global DNA Vaccination Revenue by Application (2017-2022)

Table 32. Global DNA Vaccination Revenue Forecast by Application (2023-2028)

Table 33. North America DNA Vaccination Revenue by Type (2017-2022) & (USD Million)

Table 34. North America DNA Vaccination Revenue by Type (2023-2028) & (USD Million)

Table 35. North America DNA Vaccination Revenue by Application (2017-2022) & (USD Million)

Table 36. North America DNA Vaccination Revenue by Application (2023-2028) & (USD Million)

Table 37. North America DNA Vaccination Revenue by Country (2017-2022) & (USD Million)

Table 38. North America DNA Vaccination Revenue by Country (2023-2028) & (USD Million)

Table 39. Europe DNA Vaccination Revenue by Type (2017-2022) & (USD Million)

Table 40. Europe DNA Vaccination Revenue by Type (2023-2028) & (USD Million)

Table 41. Europe DNA Vaccination Revenue by Application (2017-2022) & (USD Million)

Table 42. Europe DNA Vaccination Revenue by Application (2023-2028) & (USD Million)

Table 43. Europe DNA Vaccination Revenue by Country (2017-2022) & (USD Million)

Table 44. Europe DNA Vaccination Revenue by Country (2023-2028) & (USD Million)

Table 45. Asia-Pacific DNA Vaccination Revenue by Type (2017-2022) & (USD Million)

Table 46. Asia-Pacific DNA Vaccination Revenue by Type (2023-2028) & (USD Million)

Table 47. Asia-Pacific DNA Vaccination Revenue by Application (2017-2022) & (USD Million)

Table 48. Asia-Pacific DNA Vaccination Revenue by Application (2023-2028) & (USD Million)

Table 49. Asia-Pacific DNA Vaccination Revenue by Region (2017-2022) & (USD Million)

Table 50. Asia-Pacific DNA Vaccination Revenue by Region (2023-2028) & (USD Million)

Table 51. South America DNA Vaccination Revenue by Type (2017-2022) & (USD Million)

Table 52. South America DNA Vaccination Revenue by Type (2023-2028) & (USD Million)

Table 53. South America DNA Vaccination Revenue by Application (2017-2022) & (USD Million)

Table 54. South America DNA Vaccination Revenue by Application (2023-2028) & (USD Million)

Table 55. South America DNA Vaccination Revenue by Country (2017-2022) & (USD Million)

Table 56. South America DNA Vaccination Revenue by Country (2023-2028) & (USD Million)

Table 57. Middle East & Africa DNA Vaccination Revenue by Type (2017-2022) & (USD Million)

Table 58. Middle East & Africa DNA Vaccination Revenue by Type (2023-2028) & (USD Million)

Table 59. Middle East & Africa DNA Vaccination Revenue by Application (2017-2022) & (USD Million)

Table 60. Middle East & Africa DNA Vaccination Revenue by Application (2023-2028) & (USD Million)

Table 61. Middle East & Africa DNA Vaccination Revenue by Country (2017-2022) & (USD Million)

Table 62. Middle East & Africa DNA Vaccination Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. DNA Vaccination Picture

Figure 2. Global DNA Vaccination Revenue Market Share by Type in 2021

Figure 3. Human DNA Vaccines

Figure 4. Animal DNA Vaccines

Figure 5. DNA Vaccination Revenue Market Share by Application in 2021

Figure 6. Hospitals Picture

Figure 7. Research and Academic Laboratories Picture

Figure 8. Others Picture

Figure 9. Global DNA Vaccination Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global DNA Vaccination Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global DNA Vaccination Revenue Market Share by Region (2017-2028)

Figure 12. Global DNA Vaccination Revenue Market Share by Region in 2021

Figure 13. North America DNA Vaccination Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe DNA Vaccination Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific DNA Vaccination Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America DNA Vaccination Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa DNA Vaccination Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. DNA Vaccination Market Drivers

Figure 19. DNA Vaccination Market Restraints

Figure 20. DNA Vaccination Market Trends

Figure 21. Inovio Pharmaceuticals Recent Developments and Future Plans

Figure 22. Merck Recent Developments and Future Plans

Figure 23. Astellas Pharma Recent Developments and Future Plans

Figure 24. Pfizer Recent Developments and Future Plans

Figure 25. Global DNA Vaccination Revenue Share by Players in 2021

Figure 26. DNA Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 27. Global Top 3 Players DNA Vaccination Revenue Market Share in 2021

Figure 28. Global Top 10 Players DNA Vaccination Revenue Market Share in 2021

Figure 29. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 30. Global DNA Vaccination Revenue Share by Type in 2021

Figure 31. Global DNA Vaccination Market Share Forecast by Type (2023-2028)

Figure 32. Global DNA Vaccination Revenue Share by Application in 2021

Figure 33. Global DNA Vaccination Market Share Forecast by Application (2023-2028)

Figure 34. North America DNA Vaccination Sales Market Share by Type (2017-2028)

Figure 35. North America DNA Vaccination Sales Market Share by Application (2017-2028)

Figure 36. North America DNA Vaccination Revenue Market Share by Country (2017-2028)

Figure 37. United States DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 38. Canada DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 39. Mexico DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 40. Europe DNA Vaccination Sales Market Share by Type (2017-2028)

Figure 41. Europe DNA Vaccination Sales Market Share by Application (2017-2028)

Figure 42. Europe DNA Vaccination Revenue Market Share by Country (2017-2028)

Figure 43. Germany DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. France DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. United Kingdom DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Russia DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Italy DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Asia-Pacific DNA Vaccination Sales Market Share by Type (2017-2028)

Figure 49. Asia-Pacific DNA Vaccination Sales Market Share by Application (2017-2028)

Figure 50. Asia-Pacific DNA Vaccination Revenue Market Share by Region (2017-2028)

Figure 51. China DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Japan DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. South Korea DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. India DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Southeast Asia DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Australia DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. South America DNA Vaccination Sales Market Share by Type (2017-2028)

Figure 58. South America DNA Vaccination Sales Market Share by Application (2017-2028)

Figure 59. South America DNA Vaccination Revenue Market Share by Country (2017-2028)

Figure 60. Brazil DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Argentina DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Middle East and Africa DNA Vaccination Sales Market Share by Type (2017-2028)

Figure 63. Middle East and Africa DNA Vaccination Sales Market Share by Application (2017-2028)

Figure 64. Middle East and Africa DNA Vaccination Revenue Market Share by Country (2017-2028)

Figure 65. Turkey DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Saudi Arabia DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. UAE DNA Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Methodology

Figure 69. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz